Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. The company was founded in 2000 and is headquartered in Daejeon, South Korea.
Show more...
FAQ
Genomictree 今天的股價是多少?▼
228760.KQ 目前價格為 ₩10,660 KRW,過去 24 小時上漲了 +1.43%。在圖表上更密切關注 Genomictree 股價表現。
Genomictree 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 KOSDAQ 交易所,Genomictree 的股票以代號 228760.KQ 進行交易。
Genomictree 的股價在上漲嗎?▼
228760.KQ 股票較上週下跌 -5.58%,本月下跌 -16.06%,過去一年 Genomictree 下跌 -49%。
Genomictree 的市值是多少?▼
今天 Genomictree 的市值為 265B
Genomictree 去年的營收是多少?▼
Genomictree 去年的營收為 381.61MKRW。
Genomictree 去年的淨利是多少?▼
228760.KQ 去年的淨收益為 -1.95BKRW。
Genomictree 有多少名員工?▼
截至 September 07, 2026,公司共有 77 名員工。
Genomictree 位於哪個產業?▼
Genomictree從事於Energy產業。
Genomictree 何時完成拆股?▼
Genomictree 上次拆股發生於 September 14, 2018,比例為 1:1。
Genomictree 的總部在哪裡?▼
Genomictree 的總部位於 南韓 的 Daejeon。